16-56453276-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018233.4(OGFOD1):c.168G>A(p.Met56Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,609,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M56V) has been classified as Uncertain significance.
Frequency
Consequence
NM_018233.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OGFOD1 | NM_018233.4 | c.168G>A | p.Met56Ile | missense_variant | 2/13 | ENST00000566157.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OGFOD1 | ENST00000566157.6 | c.168G>A | p.Met56Ile | missense_variant | 2/13 | 1 | NM_018233.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000109 AC: 27AN: 247256Hom.: 0 AF XY: 0.0000824 AC XY: 11AN XY: 133532
GnomAD4 exome AF: 0.000100 AC: 146AN: 1457332Hom.: 0 Cov.: 30 AF XY: 0.0000842 AC XY: 61AN XY: 724818
GnomAD4 genome AF: 0.000256 AC: 39AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.168G>A (p.M56I) alteration is located in exon 2 (coding exon 2) of the OGFOD1 gene. This alteration results from a G to A substitution at nucleotide position 168, causing the methionine (M) at amino acid position 56 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at